These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 187943)

  • 41. The future of naltrexone.
    Renault PF
    NIDA Res Monogr; 1978; (19):340-5. PubMed ID: 106298
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic.
    Schecter A
    Am J Drug Alcohol Abuse; 1975; 2(3-4):433-42. PubMed ID: 1227301
    [No Abstract]   [Full Text] [Related]  

  • 43. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
    Schecter A; Kauders F
    Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302
    [No Abstract]   [Full Text] [Related]  

  • 44. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication.
    Brahen L; Wiechert V; Capone T
    NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727
    [No Abstract]   [Full Text] [Related]  

  • 45. Craving in heroin addicts maintained on the opiate antagonist naltrexone.
    Sideroff SI; Charuvastra VC; Jarvik ME
    Am J Drug Alcohol Abuse; 1978; 5(4):415-23. PubMed ID: 755381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naltrexone and cyclazocine. A controlled treatment study.
    Brahen LS; Capone T; Wiechert V; Desiderio D
    Arch Gen Psychiatry; 1977 Oct; 34(10):1181-4. PubMed ID: 911218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naltrexone and behavior therapy for heroin addiction.
    Rawson RA; Glazer M; Callahan EJ; Liberman RP
    NIDA Res Monogr; 1979 Jun; (25):26-43. PubMed ID: 117373
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical experiences with narcotic antagonists: cyclazocine and naloxone.
    Proc Natl Conf Methadone Treat; 1973; 1():447-51. PubMed ID: 4808183
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 50. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naltrexone and psychotherapy.
    Stone-Washton N; Resnick RB; Washton AM
    NIDA Res Monogr; 1982 Apr; 41():505-7. PubMed ID: 6811941
    [No Abstract]   [Full Text] [Related]  

  • 52. Psychopathology and mood during heroin use: acute vs chronic effects.
    Mirin SM; Meyer RE; McNamee HB
    Arch Gen Psychiatry; 1976 Dec; 33(12):1503-8. PubMed ID: 999452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Narcotic antagonist treatment: clinical experience with naltrexone.
    Lewis DC; Mayer J; Hersch RG; Black R
    Int J Addict; 1978 Aug; 13(6):961-73. PubMed ID: 730406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Research on naltrexone in the criminal justice system.
    Patapis NS; Nordstrom BR
    J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is naltrexone a cure for heroin dependence?
    Hall WD; Wodak A
    Med J Aust; 1999 Jul; 171(1):9-10. PubMed ID: 10451663
    [No Abstract]   [Full Text] [Related]  

  • 56. Naltrexone implants as treatment for heroin dependence: part II.
    Wodak A; Graham R
    Addict Biol; 2005 Jun; 10(2):202; author reply 202-4. PubMed ID: 16201030
    [No Abstract]   [Full Text] [Related]  

  • 57. Strategies for preventing heroin overdose.
    Sporer KA
    BMJ; 2003 Feb; 326(7386):442-4. PubMed ID: 12595388
    [No Abstract]   [Full Text] [Related]  

  • 58. The treatment of heroin addiction: naltrexone alone and with behavior therapy.
    Callahan EJ; Rawson RA; McCleave B; Arias R; Glazer M; Liberman RP
    Int J Addict; 1980 Aug; 15(6):795-807. PubMed ID: 7461877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of naltrexone to extinguish opioid-conditioned responses.
    O'Brien CP; Childress AR; McLellan AT; Ternes J; Ehrman RN
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):53-6. PubMed ID: 6381473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A controlled study using cyclazocine in the treatment of narcotic addiction.
    Chappel JN; Jaffe JH; Senay EC
    Am J Drug Alcohol Abuse; 1974; 1(2):233-42. PubMed ID: 4619540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.